Results of a phase 1, single-center, open-label study to assess the safety and evaluate the activity of rituximab for the treatment of pemphigus vulgaris

被引：0
|
作者：
Zeichner, Joshua
Blum, Robin
Lebwohl, Mark
Cohen, Steven
机构：
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
[2] Albert Einstein Coll Med, New York, NY USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2007年 / 56卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB116 / AB116
页数：1
相关论文
共 50 条
  • [1] A SINGLE-CENTER, OPEN-LABEL STUDY OF 1726 NM LASER FOR TREATMENT OF ACNE VULGARIS
    Bhatia, Ashish C.
    Kothare, Amogh
    [J]. LASERS IN SURGERY AND MEDICINE, 2022, 54 : S110 - S110
  • [2] An open-label phase I clinical study to assess the safety of PI-0824 in patients with pemphigus vulgaris
    Werth, VP
    Strober, BE
    Connolly, M
    Korman, N
    Greenstein, D
    Fantasia, J
    Kalish, R
    Anhalt, G
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (01) : A5 - A5
  • [3] An open-label phase I clinical study to assess the safety of PI-0824 in patients with pemphigus vulgaris
    Anhalt, G
    Werth, V
    Strober, B
    Connolly, M
    Korman, N
    Greenstein, D
    Fantasia, J
    Kalish, R
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (05) : 1088 - 1088
  • [4] Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients
    Goh, M. S. Y.
    McCormack, C.
    Dinh, H. V.
    Welsh, B.
    Foley, P.
    Prince, H. M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (05) : 990 - 996
  • [5] Single-center, open-label, efficacy and safety study of tazarotene for the treatment of brittle nails
    Sherber, Noelle
    Hoch, Ariel
    Coppola, Carol
    Mackay-Wiggan, Julian
    Scher, Richard
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB100 - AB100
  • [6] Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-Center Study
    Solak, Eda Oksum
    Gokcek, Gozde Emel
    Cinar, Salih Levent
    Kartal, Demet
    Borlu, Murat
    [J]. ERCIYES MEDICAL JOURNAL, 2021, 43 (03) : 267 - 272
  • [7] A phase 1, open-label, multicenter study to evaluate the safety and activity of rituximab in adults with relapsing-remitting multiple sclerosis (RRMS): 72 week results
    Bar-Or, Amit
    Calabresi, Peter
    Arnold, Douglas
    Markowitz, Clyde
    Shafer, Stuart
    Kasper, Lloyd
    Waubant, Emmanuelle
    Gazda, Suzanne
    Fox, Robert
    Sarkar, Neena
    Panzara, Michael
    Smith, Craig
    [J]. NEUROLOGY, 2008, 70 (11) : A119 - A120
  • [8] Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study
    Baum, Sharon
    Debby, Assaf
    Gilboa, Sarit
    Trau, Henri
    Barzilai, Aviv
    [J]. DERMATOLOGY, 2016, 232 (05) : 578 - 585
  • [9] Safety of Daiobotampito in the Treatment of Acute Diverticulitis of the Colon: A Single-Center, Open-Label, Prospective Trial
    Koike, Hiroshi
    Nakazawa, Atsushi
    Horiba, Yuko
    Tsukada, Nobuhiro
    Watanabe, Kenji
    [J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2017, 23 (11) : 885 - 889
  • [10] A Single-center, Open-label, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of the Indirect Bonding Technique
    Murakami, Takashi
    Kawanabe, Noriaki
    Kataoka, Tomoki
    Hoshijima, Mitsuhiro
    Komori, Hiroki
    Fujisawa, Atsuro
    Kamioka, Hiroshi
    [J]. ACTA MEDICA OKAYAMA, 2016, 70 (05) : 413 - 416
12345